Recent 13F filings as of September 2025 show that 189 institutional investors hold a position in Wave Life Sciences Ltd. (NASDAQ:WVE).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 18,202,009 | 0 | 0.00% | $133,238,706.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 14,567,784 | -448,716 | -2.99% | $106,636,179.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 10,430,813 | 47,097 | 0.45% | $76,353,551.00 |
| MAVERICK CAPITAL LTD | 30 Sep, 2025 | 8,391,856 | 130,173 | 1.58% | $61,428,386.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 6,298,060 | -233,459 | -3.57% | $46,101,799.00 |
| M28 Capital Management LP | 30 Sep, 2025 | 5,664,548 | 0 | 0.00% | $41,464,491.00 |
| FMR LLC | 30 Sep, 2025 | 5,130,374 | 4,511,237 | 728.63% | $37,554,335.00 |
| Kynam Capital Management, LP | 30 Sep, 2025 | 4,560,053 | 0 | 0.00% | $33,379,588.00 |
| 683 Capital Management, LLC | 30 Sep, 2025 | 4,150,000 | 50,000 | 1.22% | $30,378,001.00 |
| Bellevue Group AG | 30 Sep, 2025 | 4,094,458 | 0 | 0.00% | $29,971,433.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 4,044,492 | -1,145,911 | -22.08% | $29,607.00 |
| FEDERATED HERMES, INC. | 30 Sep, 2025 | 3,750,693 | 3,750,140 | 678,144.67% | $27,455,073.00 |
| Siren, L.L.C. | 30 Sep, 2025 | 3,696,322 | 0 | 0.00% | $27,057,077.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 3,139,836 | -337,241 | -9.70% | $22,983,600.00 |
| EMERALD ADVISERS, LLC | 30 Sep, 2025 | 2,996,900 | -260,219 | -7.99% | $21,937,308.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 2,918,370 | 158,989 | 5.76% | $21,365,183.00 |
| LOOMIS SAYLES & CO L P | 30 Sep, 2025 | 2,905,466 | -390,234 | -11.84% | $21,268,011.00 |
| STATE STREET CORP | 30 Sep, 2025 | 2,846,366 | 89,611 | 3.25% | $20,835,399.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 2,125,137 | 1,118,056 | 111.02% | $15,556,003.00 |
| STEMPOINT CAPITAL LP | 30 Sep, 2025 | 2,110,152 | 1,209,814 | 134.37% | $15,446,313.00 |